Related references
Note: Only part of the references are listed.Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study
Massimo Imazio et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout
Viola Kluck et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Erdheim-Chester disease: An in vivo human model of Mφ activation at the crossroad between chronic inflammation and cancer
Giulio Cavalli et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Autophagy and Protein Secretion
Giulio Cavalli et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
Achille Aouba et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Serena Colafrancesco et al.
AUTOIMMUNITY REVIEWS (2020)
Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
George Dimopoulos et al.
CELL HOST & MICROBE (2020)
Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic
Zahra Belhadjer et al.
CIRCULATION (2020)
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
Corrado Campochiaro et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Use of anakinra in severe COVID-19: A case report
Giovanni Filocamo et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report
Marco Franzetti et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
Emanuele Pontali et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Lucio Verdoni et al.
LANCET (2020)
Resolution of Giant Coronary Aneurisms in a Child With Refractory Kawasaki Disease Treated With Anakinra
Alessandro Gambacorta et al.
FRONTIERS IN PEDIATRICS (2020)
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
Emanuel Della-Torre et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series
Iris Navarro-Millan et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients
Serena Colafrancesco et al.
FRONTIERS IN IMMUNOLOGY (2020)
Successful treatment of severe COVID-19 with subcutaneous anakinra as a sole treatment
Andres Gonzalez-Garcia et al.
RHEUMATOLOGY (2020)
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
Dennis McGonagle et al.
LANCET RHEUMATOLOGY (2020)
Anakinra for severe forms of COVID-19: a cohort study
Thomas Huet et al.
LANCET RHEUMATOLOGY (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)
The Coagulation and Immune Systems Are Directly Linked through the Activation of Interleukin-1α by Thrombin
Laura C. Burzynski et al.
IMMUNITY (2019)
Phenotypes in Behcet's syndrome
Emire Seyahi
INTERNAL AND EMERGENCY MEDICINE (2019)
Role for nuclear interleukin-37 in the suppression of innate immunity
Suzhao Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Acute respiratory distress syndrome
Michael A. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis
Anna Birnhuber et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Behcet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils
Giacomo Emmi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Developmentally Regulated Innate Immune NFκB Signaling Mediates IL-1α Expression in the Perinatal Murine Lung
Brittany Butler et al.
FRONTIERS IN IMMUNOLOGY (2019)
The IL-1 family of cytokines and receptors in rheumatic diseases
Charles Anthony Dinarello
NATURE REVIEWS RHEUMATOLOGY (2019)
Behcet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects
M. Becatti et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Vascular Behcet's syndrome: an update
Giacomo Emmi et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
Neutralization of IL-1α ameliorates Crohn's disease-like ileitis by functional alterations of the gut microbiome
Paola Menghini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Treating the Different Phenotypes of Behcet's Syndrome
Alessandra Bettiol et al.
FRONTIERS IN IMMUNOLOGY (2019)
Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings
M. C. Maggio et al.
JOURNAL OF MEDICAL CASE REPORTS (2019)
Analysis of serum interleukin(IL)-1 alpha, IL-1 beta and IL-18 in patients with systemic sclerosis
Emily Lin et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Are neutrophilic dermatoses autoinflammatory disorders?
T. K. Satoh et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
How stress contributes to autoimmunity-lessons from Sjogren's syndrome
Fotini N. Skopouli et al.
FEBS LETTERS (2018)
Function and regulation of IL-1 alpha in inflammatory diseases and cancer
Ankit Malik et al.
IMMUNOLOGICAL REVIEWS (2018)
IL-1 and IL-1 regulatory pathways in cancer progression and therapy
Alberto Mantovani et al.
IMMUNOLOGICAL REVIEWS (2018)
Biology of IL-38 and its role in disease
Frank L. van de Veerdonk et al.
IMMUNOLOGICAL REVIEWS (2018)
Suppression of inflammation and acquired immunity by IL-37
Giulio Cavalli et al.
IMMUNOLOGICAL REVIEWS (2018)
Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8
Martina Molgora et al.
IMMUNOLOGICAL REVIEWS (2018)
Overview of the IL-1 family in innate inflammation and acquired immunity
Charles A. Dinarello
IMMUNOLOGICAL REVIEWS (2018)
Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease
Luisa Chiapparini et al.
JOURNAL OF NEUROLOGY (2018)
Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1 and Cathepsin G
Eduardo J. Folco et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series
Isabelle Kone-Paut et al.
AUTOIMMUNITY REVIEWS (2018)
IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
Te-Chia Wu et al.
CANCER RESEARCH (2018)
Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8
Janette Bester et al.
CYTOKINE (2018)
Interleukin-1 blockade in cardiovascular diseases: a clinical update
Leo F. Buckley et al.
EUROPEAN HEART JOURNAL (2018)
Comparative analysis on the dynamic of lacrimal gland damage and regeneration after Interleukin-1α or duct ligation induced dry eye disease in mice
Jana Dietrich et al.
EXPERIMENTAL EYE RESEARCH (2018)
Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism
Antonio Brucato et al.
INTERNAL AND EMERGENCY MEDICINE (2018)
Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue
Dov B. Ballak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis
Samuel T. Montgomery et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
MABp1 Targeting IL-1α for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study
Theodora Kanni et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Interleukin 1 receptor antagonist (IL1RA) gene polymorphism and levels associated with adverse outcome in severe community-acquired pneumonia in children: A hospital-based study in India
Shally Awasthi et al.
PEDIATRIC PULMONOLOGY (2018)
Redefining the ancestral origins of the interleukin-1 superfamily
Jack Rivers-Auty et al.
NATURE COMMUNICATIONS (2018)
Treating heart inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease
Alessandro Tomelleri et al.
FRONTIERS IN IMMUNOLOGY (2018)
Interleukin-1α Mediates Ozone-Induced Myeloid Differentiation Factor-88-Dependent Epithelial Tissue Injury and Inflammation
Chloe Michaudel et al.
FRONTIERS IN IMMUNOLOGY (2018)
Myocarditis: An Interleukin-1-Mediated Disease?
Giacomo De Luca et al.
FRONTIERS IN IMMUNOLOGY (2018)
The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease
Greta Pacini et al.
ONCOIMMUNOLOGY (2018)
Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition
Giacomo De Luca et al.
ANNALS OF INTERNAL MEDICINE (2018)
Cutting Edge: Dysregulated CARD9 Signaling in Neutrophils Drives Inflammation in a Mouse Model of Neutrophilic Dermatoses
Sarang Tartey et al.
JOURNAL OF IMMUNOLOGY (2018)
An Antiviral Branch of the IL-1 Signaling Pathway Restricts Immune-Evasive Virus Replication
Megan H. Orzalli et al.
MOLECULAR CELL (2018)
Interleukin-1 Receptor Antagonist Is Associated With Pediatric Acute Respiratory Distress Syndrome and Worse Outcomes in Children With Acute Respiratory Failure
Mary K. Dahmer et al.
PEDIATRIC CRITICAL CARE MEDICINE (2018)
The Inter-Relationship of Platelets with Interleukin-1 β-Mediated Inflammation in Humans
Rahajeng N. Tunjungputri et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Anakinra Therapy for Non-cancer Inflammatory Diseases
Giulio Cavalli et al.
FRONTIERS IN PHARMACOLOGY (2018)
Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase
Alessandra Marchesi et al.
ITALIAN JOURNAL OF PEDIATRICS (2018)
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks
Alessandra Marchesi et al.
ITALIAN JOURNAL OF PEDIATRICS (2018)
Advances in medical therapy for pericardial diseases
Alessandro Galluzzo et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2018)
HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
Damien Bertheloot et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Multicenter Study of a Novel Topical Interleukin-1 Receptor Inhibitor, Isunakinra, in Subjects With Moderate to Severe Dry Eye Disease
Michael H. Goldstein et al.
EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE (2017)
Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines
Danielle M. Clancy et al.
FEBS JOURNAL (2017)
High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair
Marco E. Bianchi et al.
IMMUNOLOGICAL REVIEWS (2017)
Reduction of Myocardial Ischemia-Reperfusion Injury by Inhibiting Interleukin-1 Alpha
Adolfo G. Mauro et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)
Idiopathic pulmonary fibrosis
Luca Richeldi et al.
LANCET (2017)
MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
Tamas Hickish et al.
LANCET ONCOLOGY (2017)
Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis A case report treated with high doses (8mg/kg/d) of anakinra
Federico Parisi et al.
MEDICINE (2017)
Acute Myocardial Infarction
Jeffrey L. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance
Giulio Cavalli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Interstitial lung disease in systemic sclerosis: current and future treatment
Roberto Giacomelli et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure
Giulio Cavalli et al.
FRONTIERS IN IMMUNOLOGY (2017)
Mapping and predicting mortality from systemic sclerosis
Muriel Elhai et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Acute and Recurrent Pericarditis
Massimo Imazio et al.
CARDIOLOGY CLINICS (2017)
Innate immunity in Sjogren's syndrome
Jeremy Kiripolsky et al.
CLINICAL IMMUNOLOGY (2017)
A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
RESPIRATORY RESEARCH (2017)
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behcet Disease
Matteo Becatti et al.
CIRCULATION (2016)
Neutrophilic dermatoses and autoinflammatory diseases with skin involvement-innate immune disorders
Alexander A. Navarini et al.
SEMINARS IN IMMUNOPATHOLOGY (2016)
Associations between interleukin-1 polymorphisms and susceptibility to vasculitis: a meta-analysis
G. G. Song et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2016)
Clinical and Molecular Inflammatory Response in Sjogren Syndrome-Associated Dry Eye Patients Under Desiccating Stress
Alberto Lopez-Miguel et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease
Eli L. Diamond et al.
BLOOD (2016)
Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease
Fleur Cohen-Aubart et al.
BLOOD (2016)
Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial)
Adriana H. Tremoulet et al.
CONTEMPORARY CLINICAL TRIALS (2016)
Treating Life-Threatening Myocarditis by Blocking Interleukin-1
Giulio Cavalli et al.
CRITICAL CARE MEDICINE (2016)
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial
Bita Shakoory et al.
CRITICAL CARE MEDICINE (2016)
Interleukin-1α drives the dysfunctional cross-talk of the airway epithelium and lung fibroblasts in COPD
Emmanuel T. Osei et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence The AIRTRIP Randomized Clinical Trial
Antonio Brucato et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Inositol-Triphosphate 3-Kinase C Mediates Inflammasome Activation and Treatment Response in Kawasaki Disease
Martin Prince Alphonse et al.
JOURNAL OF IMMUNOLOGY (2016)
Interleukin 1α and the inflammatory process
Nelson C. Di Paolo et al.
NATURE IMMUNOLOGY (2016)
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
Giulio Cavalli et al.
RHEUMATOLOGY (2016)
Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature
Aleksander Lenert et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
IL-1α and IL-1β-producing macrophages populate lung tumor lesions in mice
Michela Terlizzi et al.
ONCOTARGET (2016)
IL-1α is a DNA damage sensor linking genotoxic stress signaling to sterile inflammation and innate immunity (vol 5, 14756, 2015)
Idan Cohen et al.
SCIENTIFIC REPORTS (2016)
Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa A Randomized Clinical Trial
Vassiliki Tzanetakou et al.
JAMA DERMATOLOGY (2016)
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease
Elisabetta Ferrero et al.
ONCOIMMUNOLOGY (2016)
Sjogren syndrome
Pilar Brito-Zeron et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
IL-1 alpha mediates cellular cross-talk in the airway epithelial mesenchymal trophic unit
Alison R. Hill et al.
TISSUE BARRIERS (2016)
Human Lung Cancer-Derived Immunosuppressive Plasmacytoid Dendritic Cells Release IL-1α in an AIM2 Inflammasome-Dependent Manner
Rosalinda Sorrentino et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model Role of Both IL-1α and IL-1β
Youngho Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Interleukin-36 axis is modulated in patients with primary Sjogren's syndrome
F. Ciccia et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)
Yehuda Adler et al.
EUROPEAN HEART JOURNAL (2015)
Erdheim-Chester disease
Corrado Campochiaro et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)
Interdependence between Interleukin-1 and Tumor Necrosis Factor Regulates TNF-Dependent Control of Mycobacterium tuberculosis Infection
Nelson C. Di Paolo et al.
IMMUNITY (2015)
Formation of the inflammasome during cardiac allograft rejection
Keyur B. Shah et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer
David S. Hong et al.
INVESTIGATIONAL NEW DRUGS (2015)
IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs
Satoshi Nishimura et al.
JOURNAL OF CELL BIOLOGY (2015)
Upregulation of NLRP3 Inflammasome in the Tears and Ocular Surface of Dry Eye Patients
Liangliang Niu et al.
PLOS ONE (2015)
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
Allison C. Morton et al.
EUROPEAN HEART JOURNAL (2015)
IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer
Elena Voronov et al.
CANCER MICROENVIRONMENT (2015)
Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis
Yan Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up
Mei Zong et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice
Marina Bersudsky et al.
GUT (2014)
Behcet's syndrome pathophysiology and potential therapeutic targets
Giacomo Emmi et al.
INTERNAL AND EMERGENCY MEDICINE (2014)
Formation of the inflammasome in acute myocarditis
Stefano Toldo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation
Juliana Bessa et al.
JOURNAL OF AUTOIMMUNITY (2014)
Interleukin-1α neutralisation in patients with cancer
Charles Anthony Dinarello
LANCET ONCOLOGY (2014)
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
David S. Hong et al.
LANCET ONCOLOGY (2014)
IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts
M. I. Suwara et al.
MUCOSAL IMMUNOLOGY (2014)
The inflammatory response in myocardial injury, repair, and remodelling
Nikolaos G. Frangogiannis
NATURE REVIEWS CARDIOLOGY (2014)
Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth. University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Diagnosing Erdheim-Chester disease
Giulio Cavalli et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases
Giulio Cavalli et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Interleukin-1 blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse
Stefano Toldo et al.
EXPERIMENTAL PHYSIOLOGY (2013)
The heart on fire: inflammasome and cardiomyopathy
Antonio Abbate
EXPERIMENTAL PHYSIOLOGY (2013)
Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation
Yue Zheng et al.
IMMUNITY (2013)
The Interleukin-1 Family: Back to the Future
Cecilia Garlanda et al.
IMMUNITY (2013)
Serum levels of interleukin-1 in patients with systemic sclerosis
Takeo Maekawa et al.
JOURNAL OF DERMATOLOGY (2013)
Salivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling
Seshagiri-Rao Nandula et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2013)
The Role of Interleukin-1 and Interleukin-18 in Pro-Inflammatory and Anti-Viral Responses to Rhinovirus in Primary Bronchial Epithelial Cells
Sian C. Piper et al.
PLOS ONE (2013)
Negative regulatory receptors of the IL-1 family
Cecilia Garlanda et al.
SEMINARS IN IMMUNOLOGY (2013)
The interleukin-1 alpha precursor is biologically active and is likely a key alarmin in the IL-1 family of cytokines
Busun Kim et al.
FRONTIERS IN IMMUNOLOGY (2013)
Interleukin-1 and tumor necrosis factor a blockade treatment of experimental polymyositis in mice
Takahiko Sugihara et al.
ARTHRITIS AND RHEUMATISM (2012)
Interleukin-1α is the major alarmin of lung epithelial cells released during photodynamic therapy to induce inflammatory mediators in fibroblasts
E. C. Tracy et al.
BRITISH JOURNAL OF CANCER (2012)
Beh‡et Syndrome: Is It One Condition?
H. Yazici et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
Third Universal Definition of Myocardial Infarction
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
Jacques Banchereau et al.
NATURE IMMUNOLOGY (2012)
Experimental Rhinovirus Infection as a Human Model of Chronic Obstructive Pulmonary Disease Exacerbation
Patrick Mallia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
The inflammasome: an integrated view
Olaf Gross et al.
IMMUNOLOGICAL REVIEWS (2011)
Endovascular aneurysm repair reverses the increased titer and the inflammatory activity of interleukin-1α in the serum of patients with abdominal aortic aneurysm
Clara M. Yates et al.
JOURNAL OF VASCULAR SURGERY (2011)
Hughes-Stovin Syndrome
Umair Khalid et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1α
Yael Berda-Haddad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer
Gaetano Caramori et al.
THORAX (2011)
Neutrophils in the activation and regulation of innate and adaptive immunity
Alberto Mantovani et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Interleukin-1 as a Phenotypic Immunomodulator in Keratinizing Squamous Metaplasia of the Ocular Surface in Sjogren's Syndrome
Ying-Ting Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease
Achille Aouba et al.
BLOOD (2010)
Platelet interleukin-1α drives cerebrovascular inflammation
Peter Thornton et al.
BLOOD (2010)
IL-1B Polymorphism in Association With Initial Intravenous Immunoglobulin Treatment Failure in Taiwanese Children With Kawasaki Disease
Ken-Pen Weng et al.
CIRCULATION JOURNAL (2010)
IL-1: Discoveries, controversies and future directions
Charles A. Dinarello
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
IL-1 Receptor-associated Kinase M Downregulates DSS-induced Colitis
Martin Berglund et al.
INFLAMMATORY BOWEL DISEASES (2010)
IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice
Elena Voronov et al.
INTERNATIONAL IMMUNOLOGY (2010)
Epithelial Cells Promote Fibroblast Activation via IL-1α in Systemic Sclerosis
Nima Aden et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation
Idan Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Interleukin-1 alpha stimulates proinflammatory cytokine expression in human cardiac myofibroblasts
Neil A. Turner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Immunological and Inflammatory Functions of the Interleukin-1 Family
Charles A. Dinarello
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Successful Treatment of Idiopathic Recurrent Pericarditis in Children With Interleukin-1 beta Receptor Antagonist (Anakinra) An Unrecognized Autoinflammatory Disease?
Paolo Picco et al.
ARTHRITIS AND RHEUMATISM (2009)
Role of cytokines and chemokines in idiopathic inflammatory myopathies
Boel De Paepe et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function
Umesh S. Deshmukh et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2009)
An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist
Ivona Aksentijevich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Medical Progress: Myocarditis.
Leslie T. Cooper
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma
Hangjun Duan et al.
ARTHRITIS AND RHEUMATISM (2008)
Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis
Ignatios Ikonomidis et al.
CIRCULATION (2008)
Constitutive repression of interleukin-1α in endothelial cells
Gregory J. Brunn et al.
CIRCULATION RESEARCH (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Neutrophilic Dermatoses in Children
David. R. Berk et al.
PEDIATRIC DERMATOLOGY (2008)
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease - GOLD executive summary
Klaus F. Rabe et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
From COPD to chronic systemic inflammatory syndrome?
Leonardo M. Fabbri et al.
LANCET (2007)
Identification of a key pathway required for the sterile inflammatory response triggered by dying cells
Chun-Jen Chen et al.
NATURE MEDICINE (2007)
A single injection of interleukin-1 induces reversible aqueous-tear deficiency, lacrimal gland inflammation, and acinar and ductal cell proliferation
Driss Zoukhri et al.
EXPERIMENTAL EYE RESEARCH (2007)
Antiviral and immunoregulatory activities of IFN-γ depend on constitutively expressed IL-1α
Vladimir Hurgin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies
Cecilia Grundtman et al.
ARTHRITIS AND RHEUMATISM (2007)
T-889C IL-1α promoter polymorphism influences the response to oral cyclophosphamide in scleroderma patients with alveolitis
Lorenzo Beretta et al.
CLINICAL RHEUMATOLOGY (2007)
A new murine model to define the critical pathologic and therapeutic mediators of polymyositis
Takahiko Sugihara et al.
ARTHRITIS AND RHEUMATISM (2007)
The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases
H. Senzaki
ARCHIVES OF DISEASE IN CHILDHOOD (2006)
Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury
Kengo Furuichi et al.
CRITICAL CARE MEDICINE (2006)
Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease
Haruyuki Makata et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
R. M. Fleischmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia
E Pinteaux et al.
GLIA (2006)
T cell-regulated neutrophilic inflammation in autoinflammatory diseases
M Keller et al.
JOURNAL OF IMMUNOLOGY (2005)
Association between a novel human coronavirus and Kawasaki disease
F Esper et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active Behcet disease - Implication in neutrophil apoptosis dysfunction
T Kawakami et al.
ARCHIVES OF DERMATOLOGY (2004)
Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis
CML Maffei et al.
INFECTION AND IMMUNITY (2004)
Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease
J Karasneh et al.
RHEUMATOLOGY (2003)
A sequence-based map of the nine genes of the human interleukin-1 cluster
MJH Nicklin et al.
GENOMICS (2002)
Interleukin-1α expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients -: Important pathogenic features independent of inflammatory cell clusters in muscle tissue
P Englund et al.
ARTHRITIS AND RHEUMATISM (2002)
Cytokine balance in the lungs of patients with acute respiratory distress syndrome
WY Park et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Pemphigus vulgaris: The role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production
KC Bhol et al.
CLINICAL IMMUNOLOGY (2001)
Respiratory viral infections in adults with and without chronic obstructive pulmonary disease
SB Greenberg et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
